Skip to main content
All lobbying filings

Oculus Strategies, LLC

Oculus Strategies, LLC filed a Q3 report for The Livingston Group, LLC OBO Innovative Vaccine Technologies on October 7, 2025.

Lobbying for The Livingston Group, LLC OBO Innovative Vaccine Technologies · Consulting/lobbying firm

As filed: OCULUS STRATEGIES, LLC for THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES.

All filings by Oculus Strategies, LLC · Everything The Livingston Group, LLC OBO Innovative Vaccine Technologies has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 7, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • CHRISTOPHER CARON
    Previously held: LD, Senior Policy Advisor, Deputy Chief of Staff, Rep. Tom Cole (OK-4)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

HR 3838, S 2296, FY2026 National Defense Authorization Act HR 4016, S 2572, FY2026 Defense Appropriations Act (Issues relating to the development of a vaccine delivery vehicle)

 Bills named in this filing 2
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • H.R. 4016
    Department of Defense Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem